Skip to main content

S AN CLAMENTE, Calif. – May 23, 2016 – Canal 33, an innovative medical device company addressing chronic spinal pain conditions through the development of leading-edge technologies, announces the issuance of two US patents covering the use of a High Frequency Neuromodulation Catheter Device for delivering chronic spinal cord pain relief.

US Patent US8103356B2 (issued 1/24/2012) and US8075556B2 (issued 12/13/2011) serve to protect Canal 33’s proprietary radio frequency (RF) catheters which are capable of sending energy directly to patient spinal nerves, without risking permanently damaging the nerves located in the treatment region.

Lower back pain is a common problem for many patients across the world. Frequently, lower back pain can not be fully treated, and can only be managed through pain therapy treatments such as medication or massage therapy. In more extreme situations, doctors can provide pain therapy by applying radiofrequency energy to the spine. U.S. Pat. No. 5,433,739 to Sluijter teaches a radiofrequency device that can be inserted into a spinal structure to heat and kill nerve structures and deliver pain relief. Unfortunately, such a technique can be indiscriminate in its destruction and can greatly harm the patient even if used by a skilled surgeon.

Radiofrequency (RF) treatment of pain has a long history in the field of pain management, and has been extensively utilized for the treatment of spine pain due to facet joint origin, in particular. The present invention provides apparatus, systems and methods for improved delivery of pulsed radio frequency energy. The RF catheter is an integrated catheter shaft with a guidewire and a radio frequency wire, both used in a catheter to deliver radio frequency energy to a treatment site. The small entry wound and the long integrated catheter shaft allows a user to thread the shaft along a tortuous route along a spinal canal to reach a treatment site while causing a minimal amount of trauma to the patient.

ABOUT THE COMPANY: Canal 33 is a medial device company headquartered in San Clemente, California focused on developing technologies capable of delivering chronic spinal cord pain relief. The company is focused on introducing and commercializing medical devices for minimal invasive vertebral augmentation, as well as an innovative new line of radio frequency catheters capable of sending energy directly to the patient’s spinal nerves, without risking permanently damaging the nerves located in the treatment region.


This press release may contain forward-looking statements, including Canal 33’s development medical devices for treating chronic spinal pain. Each of these statements may involve risks and uncertainties. Actual results may differ materially from those, expressed or implied.

Media Contact: Richard Simpson, 858.925.5602